1981
DOI: 10.1289/ehp.813923
|View full text |Cite
|
Sign up to set email alerts
|

Chromosomal aberrations and bone marrow toxicity.

Abstract: The importance of chromosomal aberrations as a proximate cause of bone marrow toxicity is discussed. Since chemicals that can cause nondisjunction are rare, numerical aberrations (aneuploidy, polyploidy) are not ordinarily important. Many structural aberrations, however, can lead directly to cell death and so are proximate causes of toxicity when they occur. The micronucleus test which utilizes the polychromatic erythrocyte is capable of detecting agents (clastogens) that can cause such structural aberrations.… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
5
0

Year Published

1983
1983
2023
2023

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 25 publications
(5 citation statements)
references
References 8 publications
0
5
0
Order By: Relevance
“…The effect of these structures on the chromosome to form chromosome fragments or loss of centromere lead to delay of these fragments in the anaphase stage cell mitosis. After the telophase stage, these chromosome fragments are turned around to form Micronuclei 13,14 .…”
Section: Discussionmentioning
confidence: 99%
“…The effect of these structures on the chromosome to form chromosome fragments or loss of centromere lead to delay of these fragments in the anaphase stage cell mitosis. After the telophase stage, these chromosome fragments are turned around to form Micronuclei 13,14 .…”
Section: Discussionmentioning
confidence: 99%
“…The micronucleus assay was carried out by a modification of the method of Heddle and Salamone, [ 31 ]; Timwell and Ashley, [ 32 ] and blood levels of antioxidant enzymes; catalase (CAT), superoxide dismutase (SOD), reduced glutathione (GSH) and MDA was done according to the protocol of Sun and Zigma [ 33 ].…”
Section: Methodsmentioning
confidence: 99%
“…However, there are no published data available related to the genotoxic potential of magnesium stearate. For the safety assessment of food ingredients, the U.S. Food and Drug Administration (FDA) recommends a bacterial reverse mutation test [6] , [7] , [8] , an in vitro test for chromosomal damage or gene mutation in mammalian cells, as well as an in vivo test for chromosomal damage using mammalian hematopoietic cells [9] , such as the rodent erythrocyte micronucleus assay [10] , [11] which has proven utility for predicting carcinogens [12] . The European Food Safety Authority (EFSA) guidances [13] , [14] recommend a similar, albeit tiered, approach for assessing genotoxic potential.…”
Section: Introductionmentioning
confidence: 99%